Misplaced Pages

Testosterone hexahydrobenzoate

Clinical data
Trade names	Testormon Depot, Sterandryl Retard, Tardosterandryl, Testodur, Virex
Other names	THHB; Testosterone cyclohexanecarboxylate; TCHC; Testosterone 17β-cyclohexanecarboxylate
Routes of administration	Intramuscular injection
Identifiers
IUPAC name (1S,2R,10R,11S,14S,15S)-2,15-dimethyl-5-oxotetracycloheptadec-6-en-14-yl cyclohexanecarboxylate
CAS Number	14191-92-5
PubChem CID	21116124
ChemSpider	19972137
UNII	T4QOX8847Z
ECHA InfoCard	100.034.571
Chemical and physical data
Formula	C26H38O3
Molar mass	398.587 g·mol
3D model (JSmol)	Interactive image
SMILES C12CC3(1CC2OC(=O)C4CCCCC4)CCC5=CC(=O)CC35C
InChI InChI=1S/C26H38O3/c1-25-14-12-19(27)16-18(25)8-9-20-21-10-11-23(26(21,2)15-13-22(20)25)29-24(28)17-6-4-3-5-7-17/h16-17,20-23H,3-15H2,1-2H3/t20-,21-,22-,23-,25-,26-/m0/s1 Key:YKNXICSCSYLTHK-IXKNJLPQSA-N

Testosterone hexahydrobenzoate (THHB), or testosterone cyclohexanecarboxylate (TCHC), sold under the brand names Testormon Depot, Sterandryl Retard, Tardosterandryl, and Testosteron-Depot among others, is an androgen and anabolic steroid medication and a testosterone ester. It is used by intramuscular injection and is provided in the form of ampoules containing 100 mg THHB in oil solution. THHB has comparable pharmacokinetics to those of testosterone cypionate and testosterone enanthate. The medication is no longer marketed. It was previously available in Great Britain.

See also

• Nandrolone cyclohexanecarboxylate

References

1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 641–642. ISBN 978-1-4757-2085-3.
2. Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. ISBN 978-3-88763-075-1.
3. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. ISBN 978-94-011-4439-1.
4. ^ Lauritzen C (1988). "Natürliche und Synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien" [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles]. In Schneider HP, Lauritzen C, Nieschlag E (eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (in German). Walter de Gruyter. pp. 229–306. ISBN 978-3110109689. OCLC 35483492.
5. Applezweig N (1962). Steroid Drugs. Blakiston Division, McGraw-Hill. p. 441.
6. Behre HM, Nieschlag E, Behre H, Nieschlag S (26 July 2012). "Testosterone preparations for clinical use in males". In Nieschlag E, Behre HM, Nieschlag S (eds.). Testosterone: Action, Deficiency, Substitution. Cambridge University Press. pp. 309–335. doi:10.1017/CBO9781139003353.016. ISBN 978-1-107-01290-5.
7. Llewellyn W (2011). Anabolics. Molecular Nutrition Llc. ISBN 978-0-9828280-1-4.
8. Bishop PM (1958). "Endocrine Treatment of Gynaecological Disorders". In Gardiner-Hill H (ed.). Modern Trends in Endocrinology. Vol. 1. London: Butterworth & Co. pp. 231–244.

This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

This article about a steroid is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Abandoned drugs
• Anabolic–androgenic steroids
• Androstanes
• Testosterone esters
• Genito-urinary system drug stubs
• Steroid stubs